Author Topic: New MS therapy company to focus on remyelination  (Read 95 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
New MS therapy company to focus on remyelination
« on: April 07, 2018, 04:44:09 pm »
A new company has been formed to develop MS therapies involving remyelination. This article, "New MS Therapy Company, Pipeline, to Focus on Rejuvenating Nerve Cell Coating," is from Multiple Sclerosis News Today (April 6, 2018):


https://multiplesclerosisnewstoday.com/2018/04/06/ms-therapy-company-pipeline-to-focus-on-regenerating-nerve-cell-coating/?utm_source=Multiple+Sclerosis&utm_campaign=c7a793148f-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-c7a793148f-71286581
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
71 Views
Last post July 26, 2018, 03:42:33 pm
by agate
0 Replies
70 Views
Last post July 04, 2019, 07:02:49 pm
by agate
0 Replies
59 Views
Last post August 03, 2021, 08:56:50 pm
by agate
0 Replies
126 Views
Last post June 24, 2022, 09:56:39 pm
by agate
0 Replies
46 Views
Last post December 14, 2022, 09:19:21 pm
by agate